These findings suggest that genetic and environmental factors, such as metabolic diseases, influence each other in CRC and may implicate PAI-1 polymorphisms as pathophysiologic linkers/modulators between metabolic syndrome and cancer [13,14,15,16,17]. This evidence concerns the gene SERPINE1 and Other metabolic disease.